关于停止曲安奈德治疗瘢痕疙瘩和增生性疤痕的关注

IF 2 3区 医学 Q2 SURGERY
Zahra Arabi , Omar Hausien , Norbert Kang
{"title":"关于停止曲安奈德治疗瘢痕疙瘩和增生性疤痕的关注","authors":"Zahra Arabi ,&nbsp;Omar Hausien ,&nbsp;Norbert Kang","doi":"10.1016/j.bjps.2025.07.009","DOIUrl":null,"url":null,"abstract":"<div><div>Triamcinolone acetonide (TAC), a synthetic glucocorticoid, is commonly administered as an intralesional injection for patients who present in our clinics with keloid or hypertrophic scars (HTS). The use of TAC (i.e. Adcortyl® or Kenalog® supplied by Bristol-Myers-Squibb) for this purpose is also supported by many studies.<sup>1</sup> It therefore comes with great disappointment to learn the decision from Department of Health and Social Care to withdraw the license for use of Adcortyl® and Kenalog® in the UK, especially as there are limited studies evaluating the suitability of alternatives.<sup>1,3</sup> However, we encourage the investigation into the potential therapeutic effects of benzyl alcohol (15mg/ml), an excipient in Adcortyl® and Kenalog®, in the treatment of keloids and HTS in the future.<sup>5</sup></div></div>","PeriodicalId":50084,"journal":{"name":"Journal of Plastic Reconstructive and Aesthetic Surgery","volume":"108 ","pages":"Pages 8-9"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Concerns about the discontinuation of triamcinolone acetonide in the management of keloid and hypertrophic scars\",\"authors\":\"Zahra Arabi ,&nbsp;Omar Hausien ,&nbsp;Norbert Kang\",\"doi\":\"10.1016/j.bjps.2025.07.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Triamcinolone acetonide (TAC), a synthetic glucocorticoid, is commonly administered as an intralesional injection for patients who present in our clinics with keloid or hypertrophic scars (HTS). The use of TAC (i.e. Adcortyl® or Kenalog® supplied by Bristol-Myers-Squibb) for this purpose is also supported by many studies.<sup>1</sup> It therefore comes with great disappointment to learn the decision from Department of Health and Social Care to withdraw the license for use of Adcortyl® and Kenalog® in the UK, especially as there are limited studies evaluating the suitability of alternatives.<sup>1,3</sup> However, we encourage the investigation into the potential therapeutic effects of benzyl alcohol (15mg/ml), an excipient in Adcortyl® and Kenalog®, in the treatment of keloids and HTS in the future.<sup>5</sup></div></div>\",\"PeriodicalId\":50084,\"journal\":{\"name\":\"Journal of Plastic Reconstructive and Aesthetic Surgery\",\"volume\":\"108 \",\"pages\":\"Pages 8-9\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Plastic Reconstructive and Aesthetic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1748681525004255\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Plastic Reconstructive and Aesthetic Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1748681525004255","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

曲安奈德(TAC)是一种合成糖皮质激素,通常用于瘢痕疙瘩或肥厚性疤痕(HTS)患者的病灶内注射。为此目的使用TAC(即百时美施贵宝提供的Adcortyl®或Kenalog®)也得到了许多研究的支持因此,得知英国卫生和社会保障部(Department of Health and Social Care)决定撤销Adcortyl®和Kenalog®在英国的使用许可,尤其是在评估替代品适用性的研究有限的情况下,我们感到非常失望。然而,我们鼓励对苯甲醇(15mg/ml) (Adcortyl®和Kenalog®中的一种赋形剂)在治疗瘢痕疙瘩和HTS中的潜在治疗效果进行研究
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Concerns about the discontinuation of triamcinolone acetonide in the management of keloid and hypertrophic scars
Triamcinolone acetonide (TAC), a synthetic glucocorticoid, is commonly administered as an intralesional injection for patients who present in our clinics with keloid or hypertrophic scars (HTS). The use of TAC (i.e. Adcortyl® or Kenalog® supplied by Bristol-Myers-Squibb) for this purpose is also supported by many studies.1 It therefore comes with great disappointment to learn the decision from Department of Health and Social Care to withdraw the license for use of Adcortyl® and Kenalog® in the UK, especially as there are limited studies evaluating the suitability of alternatives.1,3 However, we encourage the investigation into the potential therapeutic effects of benzyl alcohol (15mg/ml), an excipient in Adcortyl® and Kenalog®, in the treatment of keloids and HTS in the future.5
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.10
自引率
11.10%
发文量
578
审稿时长
3.5 months
期刊介绍: JPRAS An International Journal of Surgical Reconstruction is one of the world''s leading international journals, covering all the reconstructive and aesthetic aspects of plastic surgery. The journal presents the latest surgical procedures with audit and outcome studies of new and established techniques in plastic surgery including: cleft lip and palate and other heads and neck surgery, hand surgery, lower limb trauma, burns, skin cancer, breast surgery and aesthetic surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信